purchase customization

Leave This Empty:

choose chapter to purchase

table of content

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Neglected Tropical Diseases Drugs and Vaccine
1.2 Key Market Segments
1.2.1 Neglected Tropical Diseases Drugs and Vaccine Segment by Type
1.2.2 Neglected Tropical Diseases Drugs and Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Neglected Tropical Diseases Drugs and Vaccine Market Overview
2.1 Global Market Overview
2.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Neglected Tropical Diseases Drugs and Vaccine Market Competitive Landscape
3.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Neglected Tropical Diseases Drugs and Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Neglected Tropical Diseases Drugs and Vaccine Sales Sites, Area Served, Product Type
3.6 Neglected Tropical Diseases Drugs and Vaccine Market Competitive Situation and Trends
3.6.1 Neglected Tropical Diseases Drugs and Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Neglected Tropical Diseases Drugs and Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Neglected Tropical Diseases Drugs and Vaccine Industry Chain Analysis
4.1 Neglected Tropical Diseases Drugs and Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Neglected Tropical Diseases Drugs and Vaccine Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Neglected Tropical Diseases Drugs and Vaccine Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Neglected Tropical Diseases Drugs and Vaccine Price by Type (2019-2024)
7 Neglected Tropical Diseases Drugs and Vaccine Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Sales by Application (2019-2024)
7.3 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Neglected Tropical Diseases Drugs and Vaccine Sales Growth Rate by Application (2019-2024)
8 Neglected Tropical Diseases Drugs and Vaccine Market Segmentation by Region
8.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.1.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Neglected Tropical Diseases Drugs and Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Neglected Tropical Diseases Drugs and Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Neglected Tropical Diseases Drugs and Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Neglected Tropical Diseases Drugs and Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Artecef BV
9.1.1 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.1.2 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.1.4 Artecef BV Business Overview
9.1.5 Artecef BV Neglected Tropical Diseases Drugs and Vaccine SWOT Analysis
9.1.6 Artecef BV Recent Developments
9.2 GlaxoSmithKline
9.2.1 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.2.2 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.2.4 GlaxoSmithKline Business Overview
9.2.5 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine SWOT Analysis
9.2.6 GlaxoSmithKline Recent Developments
9.3 AstraZeneca
9.3.1 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.3.2 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.3.4 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine SWOT Analysis
9.3.5 AstraZeneca Business Overview
9.3.6 AstraZeneca Recent Developments
9.4 Novartis
9.4.1 Novartis Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.4.2 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.4.4 Novartis Business Overview
9.4.5 Novartis Recent Developments
9.5 Sanofi-Aventis
9.5.1 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.5.2 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.5.4 Sanofi-Aventis Business Overview
9.5.5 Sanofi-Aventis Recent Developments
9.6 Ranbaxy Labs
9.6.1 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.6.2 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.6.4 Ranbaxy Labs Business Overview
9.6.5 Ranbaxy Labs Recent Developments
9.7 Lupin
9.7.1 Lupin Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.7.2 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.7.4 Lupin Business Overview
9.7.5 Lupin Recent Developments
9.8 Macleods Pharmaceuticals
9.8.1 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.8.2 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.8.4 Macleods Pharmaceuticals Business Overview
9.8.5 Macleods Pharmaceuticals Recent Developments
9.9 Cipla
9.9.1 Cipla Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.9.2 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.9.4 Cipla Business Overview
9.9.5 Cipla Recent Developments
9.10 Romark Laboratories
9.10.1 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.10.2 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.10.4 Romark Laboratories Business Overview
9.10.5 Romark Laboratories Recent Developments
9.11 Toyama Chemica
9.11.1 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Basic Information
9.11.2 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Overview
9.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Product Market Performance
9.11.4 Toyama Chemica Business Overview
9.11.5 Toyama Chemica Recent Developments
10 Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Region
10.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast
10.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Region
10.2.4 South America Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Neglected Tropical Diseases Drugs and Vaccine by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Neglected Tropical Diseases Drugs and Vaccine by Type (2025-2030)
11.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Neglected Tropical Diseases Drugs and Vaccine by Type (2025-2030)
11.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings